Aplitabart

N/A

Report date: 2025/04/20 20:00:03

Base Information

Drug NameAplitabart
Drug Alias NameIGM-8444
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 10B agonists
TargetsTumor necrosis factor receptor superfamily member 10B
Therapy Area/IndicationsSolid tumoursColorectal NeoplasmsSarcoma +[7
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaFrance +[5
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIgm Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIgm Biosciences Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursColorectal NeoplasmsSarcoma +[7

Other Information

ATC CodeN/A
Related LinksN/A